From: The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
Medication | Responders (n = 14) | Non-responders (n = 10) |
---|---|---|
Nutritional | ||
 CF specific multi-vitamin | 14 | 10 |
 Vitamin D | 14 | 10 |
 Pancreatic enzymes | 12 | 10 |
Chronic oral antibiotic therapies | ||
 Azithromycin | 11 | 9 |
 Ciprofloxacin | 2 | 2 |
 Other antibioticsa | 0 | 3 |
Inhaled antibacterial cycling | ||
 AZLI sole inhaled antibiotic | 12 | 5 |
 Tobramycin supplemented (TIS/TIP) | 1 | 4 |
 Colistin supplemented (colomycin) | 1 | 1 |
Respiratory | ||
 Short-acting beta-agonist | 11 | 9 |
 Long-acting beta-agonist | 14 | 9 |
 Inhaled corticosteroid | 8 | 2 |
 Nasal steroid | 5 | 1 |
 Dornase alpha (DNase) | 10 | 8 |
 Hypertonic saline | 8 | 6 |
Gastrointestinal | ||
 PPI (pantoprazole/omeprazole) | 4 | 6 |
 Ursodiol | 2 | 1 |
 Ultratums | 12 | 10 |
 Laxative | 3 | 4 |
Endocrine | ||
 Oral birth control pill | 2 | 1 |
 Insulin | 4 | 4 |
 Oral hypoglycemic | 1 | 2 |
Other | ||
 Antidepressant | 5 | 3 |
 NSAID | 0 | 1 |